Magic Glass Phase 3
In the Magic project Phase 3, the Ulster team was selected, along with industrial partners, as suppliers with funding to implement and trial the Magic Glass.
EU CEC-H2020-VIA Magic PCP
About the Project
In the Magic project Phase 3, the Ulster team was selected, along with industrial partners, as suppliers with funding to implement and trial the Magic Glass with stroke patients in Northern Ireland and Italy. After which, we will have the opportunity to tender in the EU-wide procurement.
Projected key outcomes
In the UK stroke is the fourth single largest cause of death. In Northern Ireland, there are 2,700 strokes each year, and 35,000 stroke survivors living in the community. Limited staff resources, coupled with the geographical distances and rural population of Northern Ireland, place significant challenges on delivering the required standard of rehabilitation to enable survivors to live more independent lives and reduce long term formal and informal care. The use of self-management approaches presents an opportunity to improve patient care in a cost-effective way.